MACROCYCLIC GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS
In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HO, Joseph Daniel MASQUELIN, Thierry Jean MÍNGUEZ ORTEGA, José Miguel CHEN, Qi FIELDS, Todd BELL, Michael Gregory BAUER, Renato Alejandro GERNERT, Douglas Linn PRIEGO SOLER, Julian WOERLY, Eric Michael CUMMING, Graham Robert RODRIGUEZ HERGUETA, Antonio AGEJAS CHICHARRO, Francisco Javier KAOUDI, Talbi Abelkader |
| description | In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4341255A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4341255A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4341255A13</originalsourceid><addsrcrecordid>eNrjZDD1dXQO8neOdPbxdFZw9wl1dnT399P18fR2VQhwDQjxdHFVMFQIcnUGsv2DFECSnsEhwTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JN41wMTYxNDI1NTR0JgIJQCXfCcn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MACROCYCLIC GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS</title><source>esp@cenet</source><creator>HO, Joseph Daniel ; MASQUELIN, Thierry Jean ; MÍNGUEZ ORTEGA, José Miguel ; CHEN, Qi ; FIELDS, Todd ; BELL, Michael Gregory ; BAUER, Renato Alejandro ; GERNERT, Douglas Linn ; PRIEGO SOLER, Julian ; WOERLY, Eric Michael ; CUMMING, Graham Robert ; RODRIGUEZ HERGUETA, Antonio ; AGEJAS CHICHARRO, Francisco Javier ; KAOUDI, Talbi Abelkader</creator><creatorcontrib>HO, Joseph Daniel ; MASQUELIN, Thierry Jean ; MÍNGUEZ ORTEGA, José Miguel ; CHEN, Qi ; FIELDS, Todd ; BELL, Michael Gregory ; BAUER, Renato Alejandro ; GERNERT, Douglas Linn ; PRIEGO SOLER, Julian ; WOERLY, Eric Michael ; CUMMING, Graham Robert ; RODRIGUEZ HERGUETA, Antonio ; AGEJAS CHICHARRO, Francisco Javier ; KAOUDI, Talbi Abelkader</creatorcontrib><description>In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240327&DB=EPODOC&CC=EP&NR=4341255A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240327&DB=EPODOC&CC=EP&NR=4341255A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HO, Joseph Daniel</creatorcontrib><creatorcontrib>MASQUELIN, Thierry Jean</creatorcontrib><creatorcontrib>MÍNGUEZ ORTEGA, José Miguel</creatorcontrib><creatorcontrib>CHEN, Qi</creatorcontrib><creatorcontrib>FIELDS, Todd</creatorcontrib><creatorcontrib>BELL, Michael Gregory</creatorcontrib><creatorcontrib>BAUER, Renato Alejandro</creatorcontrib><creatorcontrib>GERNERT, Douglas Linn</creatorcontrib><creatorcontrib>PRIEGO SOLER, Julian</creatorcontrib><creatorcontrib>WOERLY, Eric Michael</creatorcontrib><creatorcontrib>CUMMING, Graham Robert</creatorcontrib><creatorcontrib>RODRIGUEZ HERGUETA, Antonio</creatorcontrib><creatorcontrib>AGEJAS CHICHARRO, Francisco Javier</creatorcontrib><creatorcontrib>KAOUDI, Talbi Abelkader</creatorcontrib><title>MACROCYCLIC GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS</title><description>In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD1dXQO8neOdPbxdFZw9wl1dnT399P18fR2VQhwDQjxdHFVMFQIcnUGsv2DFECSnsEhwTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JN41wMTYxNDI1NTR0JgIJQCXfCcn</recordid><startdate>20240327</startdate><enddate>20240327</enddate><creator>HO, Joseph Daniel</creator><creator>MASQUELIN, Thierry Jean</creator><creator>MÍNGUEZ ORTEGA, José Miguel</creator><creator>CHEN, Qi</creator><creator>FIELDS, Todd</creator><creator>BELL, Michael Gregory</creator><creator>BAUER, Renato Alejandro</creator><creator>GERNERT, Douglas Linn</creator><creator>PRIEGO SOLER, Julian</creator><creator>WOERLY, Eric Michael</creator><creator>CUMMING, Graham Robert</creator><creator>RODRIGUEZ HERGUETA, Antonio</creator><creator>AGEJAS CHICHARRO, Francisco Javier</creator><creator>KAOUDI, Talbi Abelkader</creator><scope>EVB</scope></search><sort><creationdate>20240327</creationdate><title>MACROCYCLIC GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS</title><author>HO, Joseph Daniel ; MASQUELIN, Thierry Jean ; MÍNGUEZ ORTEGA, José Miguel ; CHEN, Qi ; FIELDS, Todd ; BELL, Michael Gregory ; BAUER, Renato Alejandro ; GERNERT, Douglas Linn ; PRIEGO SOLER, Julian ; WOERLY, Eric Michael ; CUMMING, Graham Robert ; RODRIGUEZ HERGUETA, Antonio ; AGEJAS CHICHARRO, Francisco Javier ; KAOUDI, Talbi Abelkader</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4341255A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HO, Joseph Daniel</creatorcontrib><creatorcontrib>MASQUELIN, Thierry Jean</creatorcontrib><creatorcontrib>MÍNGUEZ ORTEGA, José Miguel</creatorcontrib><creatorcontrib>CHEN, Qi</creatorcontrib><creatorcontrib>FIELDS, Todd</creatorcontrib><creatorcontrib>BELL, Michael Gregory</creatorcontrib><creatorcontrib>BAUER, Renato Alejandro</creatorcontrib><creatorcontrib>GERNERT, Douglas Linn</creatorcontrib><creatorcontrib>PRIEGO SOLER, Julian</creatorcontrib><creatorcontrib>WOERLY, Eric Michael</creatorcontrib><creatorcontrib>CUMMING, Graham Robert</creatorcontrib><creatorcontrib>RODRIGUEZ HERGUETA, Antonio</creatorcontrib><creatorcontrib>AGEJAS CHICHARRO, Francisco Javier</creatorcontrib><creatorcontrib>KAOUDI, Talbi Abelkader</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HO, Joseph Daniel</au><au>MASQUELIN, Thierry Jean</au><au>MÍNGUEZ ORTEGA, José Miguel</au><au>CHEN, Qi</au><au>FIELDS, Todd</au><au>BELL, Michael Gregory</au><au>BAUER, Renato Alejandro</au><au>GERNERT, Douglas Linn</au><au>PRIEGO SOLER, Julian</au><au>WOERLY, Eric Michael</au><au>CUMMING, Graham Robert</au><au>RODRIGUEZ HERGUETA, Antonio</au><au>AGEJAS CHICHARRO, Francisco Javier</au><au>KAOUDI, Talbi Abelkader</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MACROCYCLIC GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS</title><date>2024-03-27</date><risdate>2024</risdate><abstract>In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4341255A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | MACROCYCLIC GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T00%3A22%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HO,%20Joseph%20Daniel&rft.date=2024-03-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4341255A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |